Harvard research dean to lead US PhRMA's science and regulatory affairs portfolio
This article was originally published in SRA
Executive Summary
The US research-based pharmaceutical industry association, PhRMA, has appointed William Chin as the new vice-president of its science and regulatory affairs department1. Dr Chin, who is currently the executive dean for research at Harvard Medical School, will take over his new role effective 1 July and will also serve as a member of PhRMA's management committee.